Trulieve CLO awarded RSUs and stock options

Trulieve Cannabis Corp. reported that Chief Legal Officer Eric Powers received equity-based compensation awards.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Trulieve Cannabis Corp. reported that Chief Legal Officer Eric Powers received equity-based compensation awards. He was granted stock options for 41,668 subordinate voting shares at an exercise price of $6.40 per share, expiring on March 13, 2033, vesting in three equal annual installments starting December 1, 2026.

Powers also received 58,594 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027, and the remaining half on December 1, 2028. Following these awards, he directly owns 245,311 subordinate voting shares, and 1,000 additional shares are held indirectly by his spouse.

Insider Trade Summary

Grant/Award: 100,262 shares

Grant/Award 3 txns

Insider Powers Eric

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	41,668	$0.00	$0.00
Grant/Award	Subordinate Voting Shares	58,594	$0.00	$0.00
holding	Subordinate Voting Shares	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 41,668 contracts (Direct); Subordinate Voting Shares — 245,311 shares (Direct); Subordinate Voting Shares — 1,000 shares (Indirect, By Spouse)

Footnotes (2)

F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.
F2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Trulieve (TCNNF) grant to its Chief Legal Officer?

Trulieve granted Chief Legal Officer Eric Powers stock options and restricted stock units as compensation. He received 41,668 options with a $6.40 exercise price and 58,594 RSUs, all tied to subordinate voting shares, with multi-year vesting schedules extending through 2028.

How many Trulieve (TCNNF) stock options did Eric Powers receive and at what price?

Eric Powers received 41,668 Trulieve stock options at an exercise price of $6.40 per subordinate voting share. These options vest in three equal annual installments beginning December 1, 2026, and expire on March 13, 2033, providing long-term equity incentives.

What are the vesting terms of Eric Powers’ RSUs at Trulieve (TCNNF)?

Eric Powers’ 58,594 restricted stock units vest in two stages. According to the disclosure, 50% vest on December 1, 2027, and the remaining 50% vest on December 1, 2028, each RSU delivering one subordinate voting share upon vesting.

How many Trulieve (TCNNF) shares does Eric Powers own after these transactions?

After these awards, Eric Powers directly owns 245,311 Trulieve subordinate voting shares. In addition, 1,000 subordinate voting shares are held indirectly by his spouse, reflecting both his individual and related-party holdings as reported in the insider filing.

Are Eric Powers’ Trulieve (TCNNF) equity awards open-market purchases or compensation grants?

The reported equity awards are compensation-related grants, not open-market purchases. The Form 4 classifies both the stock options and the 58,594 subordinate voting share RSUs as acquisitions via grant or award, each at a $0.00 transaction price per share.

What does the Trulieve (TCNNF) Form 4 reveal about indirect holdings by Eric Powers?

The filing shows 1,000 Trulieve subordinate voting shares held indirectly by Eric Powers’ spouse. These indirect holdings are reported separately from his 245,311 directly owned shares, clarifying the total equity exposure associated with the Chief Legal Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/17/2026 - 05:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Powers Eric

(Last)

(First)

(Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE

32312

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Subordinate Voting Shares	03/13/2026		A		58,594⁽¹⁾	A	$0	245,311	D
Subordinate Voting Shares								1,000	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$6.4	03/13/2026		A		41,668		⁽²⁾	03/13/2033	Subordinate Voting Shares	41,668	$0	41,668	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.

2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

	/s/ Eric Powers	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR